PERSISTENT HIGH PREVALENCE OF THYROID ANTIBODIES AFTER IMMUNOSUPPRESSIVE THERAPY IN SUBJECTS WITH GLOMERULONEPHRITIS - A PROSPECTIVE 3-YEARFOLLOW-UP-STUDY
Kwa. Westman et al., PERSISTENT HIGH PREVALENCE OF THYROID ANTIBODIES AFTER IMMUNOSUPPRESSIVE THERAPY IN SUBJECTS WITH GLOMERULONEPHRITIS - A PROSPECTIVE 3-YEARFOLLOW-UP-STUDY, American journal of nephrology, 18(4), 1998, pp. 274-279
The prevalence of thyroid antibodies, indicating an autoimmune thyroid
itis, has been shown to be significantly increased in patients with au
toimmune diseases. A 3-year prospective follow-up study of 42 patients
with biopsy-confirmed glomerulonephritis is presented. Although the m
ajority of patients had been treated with immunosuppressants, the prev
alence of thyroid peroxidase antibodies was unchanged in both females
and males, 47 and 15 % respectively, at follow-up. Likewise, the preva
lence of thyroglobulin antibodies was unaffected as was that of antinu
clear antibodies (ANA) when analysing males and females together. Howe
ver, for males there was a trend to higher prevalence for ANA at follo
w-up. On the other hand, the prevalence of antineutrophil cytoplasmic
antibodies declined. Furthermore, thyroid antibodies were not restrict
ed to membranous nephropathy, and notably found in 4 out of the 8 pati
ents with vasculitis.